Neurocrine Biosciences shares owned by Roman Butler Fullerton & Co
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Roman Butler Fullerton & Co
from 13F filings
Historical chart of Roman Butler Fullerton & Co investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Roman Butler Fullerton & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Roman Butler Fullerton & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $374k | 2.2k | 174.10 |
| 2023-12-31 | $1.3M | 8.8k | 142.15 |
| 2022-12-31 | $1.3M | 12k | 108.25 |
| 2022-09-30 | $1.1M | 11k | 107.59 |
| 2020-06-30 | $905k | 7.4k | 121.93 |
More positions owned by Roman Butler Fullerton & Co
View all positions for Roman Butler Fullerton & Co